Transarterial radioembolization vs transarterial chemoembolization with drug-eluting beads for treating hepatocellular carcinoma: a cost-effectiveness analysis in Japanese healthcare system. [PDF]
Jpn J RadiolShirota G +6 more
europepmc +1 more source
Transarterial Radioembolization (TARE) Global Practice Patterns: An International Survey by the Cardiovascular and Interventional Radiology Society of Europe (CIRSE). [PDF]
Cardiovasc Intervent RadiolKeane G +6 more
europepmc +1 more source
The Apparent Diffusion Coefficient of the Paraspinal and Psoas Muscles Are of Prognostic Relevance in Patients With Hepatocellular Carcinoma Undergoing Transarterial Radioembolization. [PDF]
Cancer Diagn PrognEhrengut C +9 more
europepmc +1 more source
Related searches:
Transarterial Chemoembolization and Radioembolization
Seminars in Liver Disease, 2014Transarterial chemoembolization (TACE) and radioembolization (RE) are frequently used to treat patients with hepatocellular carcinoma who cannot receive curative therapies. Transarterial chemoembolization is a heterogeneous group of procedures; based on two positive clinical trials and three meta-analyses, conventional TACE is the standard of care for ...
Riad Salem, Bruno Sangro
exaly +3 more sources
Transarterial Radioembolization with Yttrium-90 for the Treatment of Hepatocellular Carcinoma [PDF]
Advances in Therapy, 2016 Hepatocellular carcinoma (HCC) is a common cause of worldwide mortality. Transarterial radioembolization (TARE) with yttrium-90 (Y90), a transcatheter intra-arterial procedure performed by interventional radiology, has become widely utilized in managing HCC.The following is a focused review of TARE covering its commercially available products, clinical
Ahmed Gabr +2 more
exaly +3 more sources
Role of nanoparticles in transarterial radioembolization with glass microspheres
Annals of Nuclear Medicine, 2022Transarterial Radioembolization (TARE) with 90Y-loaded glass microspheres is a locoregional treatment option for Hepatocellular Carcinoma (HCC). Post-treatment 90Y bremsstrahlung imaging using Single-Photon Emission Tomography (SPECT) is currently a gold-standard imaging modality for quantifying the delivered dose. However, the nature of bremsstrahlung
Asra Sadat, Talebi +2 more
openaire +2 more sources
To compare the manifestations of chronic liver injury following transarterial chemoembolization with those of transarterial radioembolization (TARE) in patients with neuroendocrine tumor (NET).This study consisted of an Institutional Review Board-approved single-institution retrospective analysis of NET patients who received transarterial ...
Michael Soulen +2 more
exaly +3 more sources
Transarterial Radioembolization in Hepatocellular Carcinoma
2021Hepatocellular carcinoma (HCC) is the most common primary liver tumor and fourth most common cause of cancer-related deaths worldwide. For early-stage HCC patients, liver transplantation (LT) is the best choice because it reduces new HCC lesions due to the treatment of liver cirrhosis.
Ramazan Kutlu +2 more
openaire +1 more source
Hybrid angiography-CT for transarterial radioembolization: a pictorial essay
Abdominal Radiology, 2021Although hybrid angiography-CT (Angio-CT) has a long history of use for interventional oncology procedures, its applications for transarterial radioembolization (TARE) are not as well described in the literature. This pictorial essay demonstrates a single-institution experience with the utilization of an Angio-CT system for TARE treatment of ...
Alex Lionberg +6 more
openaire +2 more sources
Transarterial Radioembolization to Impact Liver Volumetry: When and How
CardioVascular and Interventional Radiology, 2022Inadequate volume of the future liver remnant (FLR) renders many patients with liver malignancies not amenable to surgical resection. Depending on the health of the liver and the patient in general, an FLR of 25-40% is required to avoid acute post-hepatectomy liver failure.
Arash Najafi, Christoph A. Binkert
openaire +2 more sources